Cargando…

Ischemia modified albumin as a useful marker for diagnoses and management of diabetic retinopathy

OBJECTIVES: Ischemia modified albumin (IMA) may aid in the early detection and management of diabetic retinopathy (DR). In this study, we examined the relationship between IMA and DR, and the effect of intravitreal anti-vascular endothelial growth factor (anti-VEGF) on IMA levels in patients with DR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Winay, Martins, Russell Seth, Anjum, Nargis, Fatima, Syeda Sadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121944/ https://www.ncbi.nlm.nih.gov/pubmed/35634607 http://dx.doi.org/10.12669/pjms.38.4.4813

Ejemplares similares

Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy
por: Pavlovschi, Ecaterina, et al.
Publicado: (2021)

The Role of Ischemia-modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata
por: Tanacan, Efsun, et al.
Publicado: (2023)

Ischemia-modified albumin must be evaluated as an oxidative stress marker together with albumin and bilirubin in individuals with acute appendicitis
por: Reddy, Varikasuvu Seshadri, et al.
Publicado: (2015)

Investigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction
por: Hazini, Ahmet, et al.
Publicado: (2015)

Evaluation of Ischemia-Modified Albumin, Malondialdehyde, and Advanced Oxidative Protein Products as Markers of Vascular Injury in Diabetic Nephropathy
por: Ahmad, Afzal, et al.
Publicado: (2016)

Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease
por: Omma, Ahmet, et al.
Publicado: (2018)

Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium()()
por: Savci, Unsal, et al.
Publicado: (2020)

Ischemia-Modified Albumin—A Potential New Marker of Oxidative Stress in Dermatological Diseases
por: Tampa, Mircea, et al.
Publicado: (2022)

Ischemia-Modified Albumin: Origins and Clinical Implications
por: Shevtsova, Alla, et al.
Publicado: (2021)

Ischemia-Modified albumin level in type 2 diabetes mellitus—Preliminary report
por: Piwowar, Agnieszka, et al.
Publicado: (2008)

The Association between Diabetic Retinopathy and Levels of Ischemia-Modified Albumin, Total Thiol, Total Antioxidant Capacity, and Total Oxidative Stress in Serum and Aqueous Humor
por: Kirboga, Kadir, et al.
Publicado: (2014)

The Role of Ischemia Modified Albumin in Acute Pulmonary Embolism
por: Kaya, Zeynettin, et al.
Publicado: (2014)

The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia
por: Karaşin, Süleyman Serkan, et al.
Publicado: (2020)

Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease
por: Shao-gang,, et al.
Publicado: (2011)

Endothelial Dysfunction and Ischemia-Modified Albumin Levels in Males with Diabetic and Nondiabetic Erectile Dysfunction
por: Kurt, Hasan Anıl, et al.
Publicado: (2022)

Ischemia-Modified Albumin, a Novel Predictive Marker of In-Hospital Mortality in Acute Aortic Dissection Patients
por: Yang, Guifang, et al.
Publicado: (2019)

The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
por: Turedi, Suleyman, et al.
Publicado: (2008)

Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of “N-Terminal Modification” to “Fatty Acid Occupation” of Albumin
por: Oran, Ismail, et al.
Publicado: (2017)

Albumin excretion rate among patients with diabetic retinopathy
por: Aman, Makbul, et al.
Publicado: (2020)

Urinary Albumin to Creatinine Ratio to Predict Diabetic Retinopathy: The Eyes Have It!
por: Prabhu, Divya, et al.
Publicado: (2022)

Ischemia-Modified Albumin Levels in Children with Chronic Liver Disease
por: Cakir, Murat, et al.
Publicado: (2012)

Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis
por: Aydin, Ozgur, et al.
Publicado: (2014)

Ischemia Modified Albumin Can Predict Necrosis at Incarcerated Hernias
por: Kadioğlu, Hüseyin, et al.
Publicado: (2013)

Increased ischemia-modified albumin and malondialdehyde levels in videothoracoscopic surgery
por: Oncel, Mufide, et al.
Publicado: (2016)

Evaluation of Ischemia-Modified Albumin and C-Reactive Protein in Type 2 Diabetics With and Without Ketosis
por: Ma, Shao-gang, et al.
Publicado: (2012)

Evaluation of the Relationship Between Microalbuminuria and Urine Ischemia‐Modified Albumin Levels in Patients with Diabetic Nephropathy
por: Bilgi, Mustafa, et al.
Publicado: (2016)

Thiol/Disulphide Homeostasis, Ischemia Modified Albumin, and Ferroxidase as Oxidative Stress Markers in Women with Obesity with Insulin Resistance
por: Ates, Elif, et al.
Publicado: (2019)

Correlation of Ischemia-Modified Albumin with SOFA and APACHE II Scores in Preoperative Patients with Colorectal Cancer
por: Satoh, Masaaki, et al.
Publicado: (2014)

Epidermal growth factor receptor rs17337023 polymorphism in hypertensive gestational diabetic women: A pilot study
por: Martins, Russell S, et al.
Publicado: (2019)

The neutrophil percentage‐to‐albumin ratio is related to the occurrence of diabetic retinopathy
por: He, Xiaojie, et al.
Publicado: (2022)

Ischemia modified albumin: does it change during pneumoperitoneum in robotic prostatectomies?
por: Ozgen, Serpil Ustalar, et al.
Publicado: (2016)

Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding
por: Coverdale, James P.C., et al.
Publicado: (2018)

Role of ischemia-modified albumin in patients with acute decompensated heart failure
por: Pan, Defeng, et al.
Publicado: (2016)

Correlation between ischemia-modified albumin level and coronary collateral circulation
por: Chen, Xin, et al.
Publicado: (2020)

Evaluation of the role of ischemia modified albumin in neonatal hypoxic-ischemic encephalopathy
por: Talat, Mohamed A., et al.
Publicado: (2020)

The Effect of Continuous Ventilation on Thiol-Disulphide Homeostasis and Albumin-Adjusted Ischemia-Modified Albumin During Cardiopulmonary Bypass
por: Ozgunay, Seyda Efsun, et al.
Publicado: (2019)

Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery
por: Kanko, Muhip, et al.
Publicado: (2012)

The ischemia modified albumin and mean platelet volume levels in patients with Behçet’s disease
por: Kılıç, Sevilay, et al.
Publicado: (2016)

Changes in ischemia-modified albumin in myocardial toxicity induced by anthracycline and docetaxel chemotherapy
por: Luan, Xiao-Dong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e31g76gqjotgpdbb6gtfbi0hpg